Cancer of the corpus
uteri, or endometrium, is the fourth most common cancer among women in the United
States. The racial and ethnic diversity of endometrial cancer follows a pattern
similar to that of breast cancer. Women with the highest age-adjusted incidence
of endometrial cancer in the SEER areas include Hawaiians, whites, Japanese
and blacks. The lowest rates occur among Korean, Vietnamese, and American Indian
women.
Endometrial cancer increases
with advancing age in most, but not all, racial/ethnic groups. Exceptions to
this general pattern are Chinese and Filipino women, among whom the highest
rates occur at ages 55-69 years. In younger women, ages 30-54 at diagnosis,
endometrial cancer is most common among Hawaiians, Japanese, and whites. At
ages 55-69 years, endometrial cancer rates are highest for white, Hawaiian,
and black women. At ages 70 years and older, rates are highest among white,
black, and Japanese women. There were too few cases in Hawaiian women ages 70
years and older to calculate a rate.
Age-adjusted mortality
rates in the United States are highest among Hawaiian women, followed by black
women. Mortality among white, Hispanic, Chinese, Japanese and Filipino women
is less than one-half the rate for Hawaiian women. Age- specific mortality is
highest among black women in each of the three age groups (there were too few
deaths among Hawaiian women to calculate rates by age). The ratio of incidence
to mortality for black women is slightly over two and for Hawaiian women it
is nearly three. Chinese women have incidence rates about five times higher
than mortality, for white women the ratio is seven, for Japanese women it is
nearly eight, and for Filipino women it is about nine. The smaller incidence-to-mortality
ratios among black and Hawaiian women suggest that access to care may be a more
acute problem for them.
Endometrial cancer is associated
with obesity and, possibly, with abnormal glucose tolerance and diabetes. The
predominant risk factor for this cancer is the use of exogenous menopausal estrogens.
When menopausal estrogens are taken with progesterone, the elevation in risk
is greatly reduced. Tamoxifen, a drug that is widely used to treat breast cancer,
appears to have estrogen-like effects on the uterus, and may also be associated
with increased risk of endometrial cancer. Excepting these risk factors, the
epidemiology of endometrial cancer is not well defined.
Source: Miller BA,
Kolonel LN, Bernstein L, Young, Jr. JL, Swanson GM, West D, Key CR, Liff JM,
Glover CS, Alexander GA, et al. (eds). Racial/Ethnic Patterns of Cancer in the
United States 1988-1992, National Cancer Institute. NIH Pub. No. 96-4104. Bethesda,
MD, 1996.
Graphs showing incidence and mortality for specific racial and ethnic
groups including information that may not be discussed in the text above,
is available at the NCI's Surveillance, Epidemiology, and End Results
(SEER) Web site at: http://seer.cancer.gov/.
Back to Top |